EU OKs Novartis’ Tafinlar/Mekinist combo for lung cancer
admin 3rd April 2017 Uncategorised 0European regulators have expanded the scope of Novartis’ Tafinlar/Mekinist combination to include the treatment of patients with a certain form of lung cancer.
More: EU OKs Novartis’ Tafinlar/Mekinist combo for lung cancer
Source: News